These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10342944)

  • 1. Cefpodoxime: new dosage. A new, unproven, dose regimen.
    Prescrire Int; 1998 Aug; 7(36):101-2. PubMed ID: 10342944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharyngitis/tonsillitis: European and United States experience with cefpodoxime proxetil.
    Dajani AS
    Pediatr Infect Dis J; 1995 Apr; 14(4 Suppl):S7-11. PubMed ID: 7792129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of oral cefpodoxime proxetil and penicillin V potassium in the treatment of group A streptococcal pharyngitis/tonsillitis. The Cefpodoxime Pharyngitis Study Group.
    Brown RJ; Batts DH; Hughes GS; Greenwald CA
    Clin Ther; 1991; 13(5):579-88. PubMed ID: 1799915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children.
    Pichichero ME; Gooch WM; Rodriguez W; Blumer JL; Aronoff SC; Jacobs RF; Musser JM
    Arch Pediatr Adolesc Med; 1994 Oct; 148(10):1053-60. PubMed ID: 7921095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter trial of cefpodoxime proxetil vs. amoxicillin-clavulanate in acute lower respiratory tract infections in childhood. International Study Group.
    Klein M
    Pediatr Infect Dis J; 1995 Apr; 14(4 Suppl):S19-22. PubMed ID: 7792126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin.
    Portier H; Chavanet P; Waldner-Combernoux A; Kisterman JP; Grey PC; Ichou F; Safran C
    Scand J Infect Dis; 1994; 26(1):59-66. PubMed ID: 8191242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children.
    Block SL; Schmier JK; Notario GF; Akinlade BK; Busman TA; Mackinnon GE; Halpern MT; Nilius AM
    Curr Med Res Opin; 2006 Sep; 22(9):1839-47. PubMed ID: 16968587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of once daily cefpodoxime proxetil suspension and thrice daily cefaclor suspension in the treatment of acute otitis media in children.
    Tsai HY; Huang LM; Chiu HH; Hsueh PR; Lee PI; Lu CY; Chiu TF; Lin HC; Lee CY
    J Microbiol Immunol Infect; 1998 Sep; 31(3):165-70. PubMed ID: 10496153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost saving of 5-day therapy with cefpodoxime proxetil versus standard 10-day beta-lactam therapy for recurrent pharyngotonsillitis in adults. A prospective general practice study.
    Pelc A; Portier H; Gehanno P; Fiessinger S; Ichou F
    Pharmacoeconomics; 1996 Sep; 10(3):239-50. PubMed ID: 10172792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison between penicillin and amoxicillin-clavulanic acid for the treatment of recurrent tonsillopharyngitis in childhood].
    Asensi F; López-Hontangas JL; Otero M; Santos M; Román J; Pérez-Tamarit D
    Rev Esp Quimioter; 1999 Sep; 12(3):211-4. PubMed ID: 10878510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five day treatment of pharyngotonsillitis with cefpodoxime proxetil.
    Portier H; Chavanet P; Gouyon JB; Guetat F
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():79-85. PubMed ID: 2127268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
    White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
    J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disc diffusion-based screening tests for extended-spectrum beta-lactamases in Haemophilus influenzae.
    Tristram SG; Bozdogan B; Appelbaum PC
    J Antimicrob Chemother; 2005 Apr; 55(4):570-3. PubMed ID: 15728142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of cefaclor vs. amoxicillin/clavulanate in tonsillopharyngitis.
    Haczyński J; Bardadin J; Gryczyńska D; Gryczyński M; Gołabek W; Kawalski H; Kaźmierczak H; Krecicki T; Kubik P; Namysłowski G; Popiel L
    Med Sci Monit; 2001; 7(5):1016-22. PubMed ID: 11535952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative trial of the clinical efficacy and tolerance of cefatrizine (Cefaperos) and cefpodoxime proxetil (Orelox) in superinfections of chronic obstructive bronchopneumopathies in adults in urban practice].
    Brambilla C; Benhamou D; Guérin JC; Kelkel E; Muir JF; Prud'homme A; Taytard A; Fauche A
    Pathol Biol (Paris); 1995 Nov; 43(9):815-24. PubMed ID: 8746104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of cefpodoxime in the prophylaxis of recurrent pharyngotonsillitis.
    Mora R; Salami A; Mora F; Cordone MP; Ottoboni S; Passali GC; Barbieri M
    Int J Pediatr Otorhinolaryngol; 2003 Dec; 67 Suppl 1():S225-8. PubMed ID: 14662201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of symptomatic relapses of group A beta-hemolytic streptococcal tonsillopharyngitis in children from 4 pediatric practices following penicillin, amoxicillin, and cephalosporin antibiotic treatment.
    Casey JR; Kahn R; Gmoser D; Atlas E; Urbani K; Luber S; Pellman H; Pichichero ME
    Clin Pediatr (Phila); 2008 Jul; 47(6):549-54. PubMed ID: 18490665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcal pharyngitis therapy: comparison of cyclacillin, cephalexin, and potassium penicillin V.
    Stillerman M; Isenberg HD
    Antimicrob Agents Chemother (Bethesda); 1970; 10():270-6. PubMed ID: 5000259
    [No Abstract]   [Full Text] [Related]  

  • 20. Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience.
    Rakkar S; Roberts K; Towe BF; Flores SM; Heyd A; Warner J
    Int J Clin Pract; 2001 Jun; 55(5):309-15. PubMed ID: 11452678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.